- Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
- Biohaven Announces Proposed Public Offering of Common Shares
- Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates
- Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
Key statistics
As of last trade Biohaven Ltd (BHVN:NYQ) traded at 42.16, -32.23% below its 52-week high of 62.21, set on Mar 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | 41.60 |
Offer | 43.26 |
Previous close | 42.16 |
Average volume | 1.54m |
---|---|
Shares outstanding | 81.66m |
Free float | 65.72m |
P/E (TTM) | -- |
Market cap | 3.44bn USD |
EPS (TTM) | -5.67 USD |
Data delayed at least 15 minutes, as of Apr 18 2024 21:10 BST.
More ▼